Home›Companies›Healthcare›Vesica Health

Vesica Health, Inc.

A urine test helps physicians assess bladder cancer risk in patients with blood in their urine.

Updated Nov 10, 2026·Latest SEC filing Mar 17, 2026·Suggest an edit

About Vesica Health

Vesica Health is a private company based in Irvine, California, incorporated in 2022 in Delaware. It has reported $4,467,683 raised in one offering on Form D since March 2026. Its chief executive is Christopher Thibodeau.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 3, 2026Mar 17, 2026$4,467,683of $4.6M target12$372KEquity, Options, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Vesica Health's Form D filed Mar 17, 2026.

CT
Christopher Thibodeau
Chief Executive Officer and director
JG
Jan Groen
Chair of the Board
MM
Mark McDonough
Independent Director
JS
Joseph Sollee
Independent Director

Sources

  1. SECVesica Health, Inc. filing history
  2. CompanyAssureMDx billing code announcement
  3. CompanyScientific advisory board announcement
  4. PressBoard appointments announcement